All Type of News
KPMA, KoreaBio to cooperate
Cooperation between the Korea Pharmaceutical Manufacturers Association (KPMA) and Korea Biotechnology Industry Organization (KBIO) is picking up, with efforts being made to step up exchanges in the areas of mutual dev...
KPWA, drugmakers agree to maintain wholesaler margin
The Korea Pharmaceutical Wholesaler Association (KPWA) and three drug firms, such as Kukje Pharmaceutical, Arlico Korea Pharmaceutical and Dongkoo Pharmaceutical, recently agreed not to lower the current wholesaler ma...
KPMA vows to stem predatory pricing in hospital biddings
The Korea Pharmaceutical Manufacturers Association (KPMA) on Tuesday vowed to stem the long-standing drug dumpling practice in hospital bidding sector and set the market order straight.
To this end, the KPMA sent ...
KFDA to implement CRO grading system from 2015
The national health watchdog said Wednesday that it will screen the quality of clinical research organizations (CROs) designated by the Korea Food and Drug Administration over the next two years.
Under the plan, th...
KRPIA names new vice chairmenPaul Henry Huibers, CEO of Eli Lilly Korea, was elected this week as vice chairmen of the Korean Research-based Pharmaceutical Industry Association, one of the largest organizat...
|
Dong-A to face criminal suit
A criminal court in Seoul will scrutinize seven former and incumbent of Dong-A Pharmaceutical Co. and two agencies on March 12 on charges of offering kickbacks to doctors and hospital officials.
Earlier last month,...
Local drug makers urged to seek generic drug exclusivity
Under the Korea-US free trade agreement (KORUS FTA), which came into effect last March, Korea has to introduce so called approval-patent linkage system. Relevant articles of the KORUS FTA prescribes that Korea has to ...
W100 billion fund to be set up for small drug companies
Korea has unveiled an ambitious vision to foster global pharmaceutical firms through the creation of a large-scale R&D fund and offering various tax benefits to local companies.
The Ministry of Health and Welfare s...
Listed drug firms likely to cut dividend payouts on worst profits
Korean pharmaceutical listed firms are considering slashing their cash dividends to be paid out to their shareholders this year as most of their operating profits and net incomes tumbled by more than 10 percent last y...
Doctors, pharmacists clash over soaring medical spending
Disputes are arising between doctors and pharmacists over who is deteriorating the health insurance’s finance.
While doctors argue that pharmacy’s dispensing charges are responsible for aggravating overall finance ...
